Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Hyperactivity Disorder

Explore clinical trials studying Attention Deficit Hyperactivity Disorder. Study availability and eligibility vary by location and protocol.

453 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Hyperactivity Disorder trial results

Completed

Resources to Enhance the Adjustment of Children (REACH)

NCT00820001

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +4 more
Locations
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Bellefield Towers - Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)

NCT00443391

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Site Reference ID/Investigator# 6109 Mesa, Arizona, United States
  • Site Reference ID/Investigator# 6765 Mesa, Arizona, United States
  • Site Reference ID/Investigator# 6100 Lafayette, California, United States
  • Site Reference ID/Investigator# 6107 San Diego, California, United States
View all 21 locations
View Trial Details
Completed

A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder

NCT00969618

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukushima, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
View Trial Details
Completed

Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder

NCT00962104

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukushima, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
View all 24 locations
View Trial Details
Completed

Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

NCT00315276

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +3 more
Locations
  • Neurology Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Bay Area Research Institute Lafayette, California, United States
  • Pharmacology Research Institute Northridge, California, United States
  • Peninsula Research Associates Rolling Hills Estates, California, United States
View all 18 locations
View Trial Details
Completed

An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00337285

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorder, +4 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • University of California, Irvine Child Development Center Irvine, California, United States
  • Bay Area Research Institute Lafayette, California, United States
View all 45 locations
View Trial Details

Related conditions